Effect of the RET inhibitor vandetanib in a patient with RET fusion-positive metastatic non-small-cell lung cancer

Gerald S. Falchook; Nelson G. Ordonez; Christel C. Bastida; Philip J. Stephens; Vincent A. Miller; Lindsay Gaido; Tiffiny Jackson; Daniel D. Karp

doi:10.1200/JCO.2013.50.5016

Effect of the RET inhibitor vandetanib in a patient with RET fusion-positive metastatic non-small-cell lung cancer

Gerald S. Falchook, Nelson G. Ordonez, Christel C. Bastida, Philip J. Stephens, Vincent A. Miller, Lindsay Gaido, Tiffiny Jackson, Daniel D. Karp

Research output: Contribution to journal › Article › peer-review

50 Scopus citations

Original language	English (US)
Pages (from-to)	e141-e144
Journal	Journal of Clinical Oncology
Volume	34
Issue number	15
DOIs	https://doi.org/10.1200/JCO.2013.50.5016
State	Published - May 20 2016

ASJC Scopus subject areas

Cancer Research
Oncology

Access to Document

10.1200/JCO.2013.50.5016

Cite this

@article{faaa2d2c34b44c09b5e8db70e15bb60d,

title = "Effect of the RET inhibitor vandetanib in a patient with RET fusion-positive metastatic non-small-cell lung cancer",

author = "Falchook, {Gerald S.} and Ordonez, {Nelson G.} and Bastida, {Christel C.} and Stephens, {Philip J.} and Miller, {Vincent A.} and Lindsay Gaido and Tiffiny Jackson and Karp, {Daniel D.}",

year = "2016",

month = may,

day = "20",

doi = "10.1200/JCO.2013.50.5016",

language = "English (US)",

volume = "34",

pages = "e141--e144",

journal = "Journal of Clinical Oncology",

issn = "0732-183X",

publisher = "Lippincott Williams and Wilkins",

number = "15",

}

TY - JOUR

T1 - Effect of the RET inhibitor vandetanib in a patient with RET fusion-positive metastatic non-small-cell lung cancer

AU - Falchook, Gerald S.

AU - Ordonez, Nelson G.

AU - Bastida, Christel C.

AU - Stephens, Philip J.

AU - Miller, Vincent A.

AU - Gaido, Lindsay

AU - Jackson, Tiffiny

AU - Karp, Daniel D.

PY - 2016/5/20

Y1 - 2016/5/20

UR - http://www.scopus.com/inward/record.url?scp=84969533090&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84969533090&partnerID=8YFLogxK

U2 - 10.1200/JCO.2013.50.5016

DO - 10.1200/JCO.2013.50.5016

M3 - Article

C2 - 25366691

SN - 0732-183X

VL - 34

SP - e141-e144

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

IS - 15

ER -

Effect of the RET inhibitor vandetanib in a patient with RET fusion-positive metastatic non-small-cell lung cancer

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this